HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Siltuximab for Multicentric Castleman Disease-Letter.

AuthorsRaphael Teipel, Rainer Ordemann, Ulrike Proske, Frank Dietrich, Marika Mende, Gerhard Ehninger, Frank Kroschinsky, Uwe Platzbecker
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 21 Issue 20 Pg. 4740 (Oct 15 2015) ISSN: 1557-3265 [Electronic] United States
PMID26473194 (Publication Type: Letter, Comment)
Chemical References
  • Antibodies, Monoclonal
  • Antineoplastic Agents
Topics
  • Animals
  • Antibodies, Monoclonal (therapeutic use)
  • Antineoplastic Agents (therapeutic use)
  • Castleman Disease (drug therapy)
  • Drug Approval
  • Humans
  • United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: